MS Healthcare Conference: EU Pharma Day 2 wrap

Research evidence excerpt

Not for redistribution without written consent of Morgan Stanley

M

Update

September 15, 2026 11:10 PM GMT

Pharmaceuticals | Europe

Morgan Stanley & Co. International plc+

Sarita Kapila

Equity Analyst

MS Healthcare Conference: EU

Pharma Day 2 wrap

Thibault Boutherin

Equity Analyst

Adithya Venkat

Research Associate

We include inside the note the key takeaways from day 2 of the

conference for Alvotech, GSK, Lonza, Sandoz and Sanofi.

Pharmaceuticals

Europe

Industry View

In-Line

Morgan Stanley does and seeks to do business with

companies covered in Morgan Stanley Research. As a result,

investors should be aware that the firm may have a conflict of

interest that could affect the objectivity of Morgan Stanley

Research. Investors should consider Morgan Stanley

Research as only a single factor in making their investment

decision.